Literature DB >> 20110849

A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.

Binu S Mathew1, Denise H Fleming, Vellaichamy M Annapandian, Samuel Prasanna, Chennaveera G Prasanna, Sujith J Chandy, George T John.   

Abstract

In renal transplant patients, there is an established relationship between mycophenolate area under the curve and clinical outcome. The authors have developed and validated a limited sampling strategy to estimate mycophenolic acid area under the curve to 12 hours (MPA AUC0-12) in a stable renal transplant Indian population prescribed a formulation of mycophenolate mofetil (Mofilet) along with prednisolone and tacrolimus. Intensive pharmacokinetic sampling was performed in 29 patients to measure mycophenolate concentration from trough to 12 hours postdose. Subsets of different timed concentrations against total measured 12-hour area under the curve were analyzed by linear regression. Three models were identified and linear regression analysis done. After all subset regression analysis, three, four, and five time point limited sampling strategies (LSS) were developed having correlation coefficients above 0.92. Validation of the models was performed using the jackknife method and their predictive performances were tested. After validation, the correlation coefficients for all three models were above 0.901. The five-point LSS had the best predictive performance with a bias (95% confidence interval) of 0.67% (-3.45 to 4.79) and mean precision 7.73%. In all patients except one, the five-point LSS estimation for total area under the curve was within +/- 20% of the total measured AUC0-12. Trough concentration had a significant correlation with AUC0-12 (r = 0.69). However, if dosing in routine clinical practice was adjusted based only on trough concentration, 41% of our patients would require a different dose compared with monitoring using AUC0-12. The five-point LSS uses half-hourly samples from trough to 1.5 hour postdose with an additional sample at 3 hours. Ninety-three percent of our patients had a Cmax within 1.5 hour and inclusion of all the time points up to1.5 hour gave a better estimate of AUC0-12. This model simplifies area under the curve measurement with high precision in stable adult renal transplant patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110849     DOI: 10.1097/FTD.0b013e3181cd550f

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

1.  Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.

Authors:  Eileen B Lawson; Jerry C Wu; R Michael Baldwin; Magnus Ingelman-Sundberg; Staffan Rosenborg; Dong-Seok Yim; Ophelia Q P Yin; Edmund V Capparelli; Joseph D Ma
Journal:  Eur J Clin Pharmacol       Date:  2011-10-19       Impact factor: 2.953

Review 2.  How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?

Authors:  Azrin N Abd Rahman; Susan E Tett; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2014-03       Impact factor: 6.447

3.  Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients.

Authors:  Jun Zhang; Zhi Sun; Zhenfeng Zhu; Jing Yang; Jian Kang; Guiwen Feng; Lin Zhou; Lihua Zuo; Yonggang Luo; Xiaojian Zhang
Journal:  Front Pharmacol       Date:  2018-08-13       Impact factor: 5.810

4.  A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration-Time Curve Estimation.

Authors:  Joanna Sobiak; Matylda Resztak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-09-04       Impact factor: 2.441

5.  A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial.

Authors:  Dwarakanathan Ranganathan; George T John; Helen Healy; Matthew J Roberts; Robert G Fassett; Jeffrey Lipman; Paul Kubler; Jacobus Ungerer; Brett C McWhinney; Aaron Lim; Megan Purvey; Reza Reyaldeen; Jason A Roberts
Journal:  BMJ Open       Date:  2013-08-07       Impact factor: 2.692

6.  Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus.

Authors:  R Prabha; B S Mathew; V Jeyaseelan; T S Kumar; I Agarwal; D H Fleming
Journal:  Indian J Nephrol       Date:  2016 Nov-Dec

7.  Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis.

Authors:  Zhihong Lu; Junfeng Song; Jianhua Mao; Yonghui Xia; Caiyun Wang
Journal:  Med Sci Monit       Date:  2017-05-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.